Lyotropic Delivery Systems (LDS) has developed a unique nanotechnology, in order to improve the transport and to enhance the efficiency and effectiveness of pharmaceuticals and biological active ingredients in generic (existing medications), as well as in those currently being developed (innovative drugs). The company’s founders, Prof. Nissim Garti and Dr. Sharon Garti-Levi, discuss the characteristic and the nature of the novel transport vehicles, mechanisms and their importance and relevance of increasing the drug performance to improve patients’ quality of life
Menu
